These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors. Klopman G, Buyukbingol E. Mol Pharmacol; 1988 Dec; 34(6):852-62. PubMed ID: 3143909 [Abstract] [Full Text] [Related]
52. Inhibition of human placenta aldose reductase by tannic acid. Sawada H, Hamatake M, Hara A, Nakagawa M, Nakayama T. Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1662-4. PubMed ID: 2505942 [Abstract] [Full Text] [Related]
54. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase. DeRuiter J, Brubaker AN, Millen J, Riley TN. J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783 [Abstract] [Full Text] [Related]
55. In vitro aldose reductase inhibitory activity of substituted N-benzenesulfonylglycine derivatives. DeRuiter J, Brubaker AN, Garner MA, Barksdale JM, Mayfield CA. J Pharm Sci; 1987 Feb; 76(2):149-52. PubMed ID: 3106615 [Abstract] [Full Text] [Related]